4 models fit Grupo Carso and they disagree: 1 of 4 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Silver65
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
ACCE opinionGrupo Carso (GCARSOA1.MX)
Fair value (4 models)
MXN 93.53
ACCE price target
MXN 145
Rating
Overvalued
Horizon
12 months
Fair value published on 24 Oct 2026, 17:04 CEST; previously MXN 100 since 18 Oct 2026, 00:00 CEST.
ACCE price target published on 17 Oct 2026, 00:00 CEST.
Rating published on 24 Oct 2026, 17:04 CEST.
Price used: MXN 166 at the close on 23 Oct 2026, 23:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
77.5% above
-43.7% to fair value
ACCE score
60
out of 100
P/E
35.3x
forward 17.6x
1-year return
+34.6%
Dividend yield
0.00%
Grupo Carso in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Grupo Carso is a Mexican holding company with a conglomerate footprint, and the data I have gives no detail on its segments, so the business mix needs to be confirmed from filings before anything else. At 363.5B MXN in market cap it is a meaningful domestic name, trading at 34.6x trailing and 27.8x forward earnings, which implies the market expects earnings to rise roughly a quarter over the next year. I cannot identify a specific competitive advantage or near-term catalyst from the figures provided, and revenue growth, ROE and margins are all unavailable, so there is no operating evidence yet to test that earnings step-up against. The stock carries no index membership and no composite score, which suggests it sits outside the screens that would normally surface it. It merits a deeper look only if the segment disclosures and margin history show the forward earnings path is credible.